DelistingJul 31, 2026, 04:24 PM
Traws Pharma receives Nasdaq delisting notice for low bid price
AI Summary
Traws Pharma, Inc. received a notification from Nasdaq on July 29, 2026, indicating non-compliance with the minimum bid price requirement. The company's common stock traded below $1.00 per share for 30 consecutive business days. Traws Pharma has 180 calendar days, until January 25, 2027, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days. The notice does not immediately impact the stock's listing, and the company plans to monitor the situation and explore options to resolve the deficiency.
Key Highlights
- Traws Pharma received a Nasdaq notification on July 29, 2026, regarding non-compliance with minimum bid price.
- The company's common stock closing bid price was below $1.00 per share for 30 consecutive business days.
- Traws Pharma has 180 calendar days, until January 25, 2027, to regain compliance.
- To regain compliance, the stock must close at or above $1.00 per share for at least 10 consecutive business days.
- The notification does not immediately affect the listing of the company's common stock on Nasdaq.
- The company intends to monitor the bid price and consider options to resolve the deficiency.
- Failure to regain compliance could lead to delisting, with a potential second 180-day grace period or appeal.
Price Impact
More from TRAW